Lymphoma Working Party (LWP)
Study number:
2021-R-01
Type of Stem Cell Treatment:
Diseases:
Short title:
EBMT alloSCT & CAR T cells
Primary objective:
Key inclusion criteria:
Country:
Principal investigator:
Bertram Glass
EBMT Study coordinator:
Hervé Finel
Study coordinator email:
herve.finel@upmc.fr